stroke
Conditions
Interventions
Minor stroke group (NIHSS<=4):none
moderate stroke group (5<=NIHSS<=15):none
moderate-severe stroke group (16<=NIHSS<=20):none
severe stroke group (21<=NIHSS<=42),:none
control group (healthy adults):none
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 74 Years
Inclusion criteria
Inclusion criteria: 1) Age 18 and above, under 75; Both sexes; 2) Diagnosed as ischemic stroke by imaging methods such as CT or magnetic resonance imaging (MRI), and diagnosed as ischemic stroke by a neurologist. 3) Understand and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Patients with a history of ischemic stroke and/or lacunar infarction, combined with sequelae such as cognitive impairment and limb disorders; 2) Cranial imaging examination confirmed the presence of diseases causing similar symptoms, such as brain tumors, encephalitis, brain abscesses, or confirmed hemorrhagic cerebral infarction, epidural hematoma, etc.; 3) Patients with severe heart disease, severe arrhythmia or heart failure; 4) Patients with severe abnormal liver and kidney function (liver function laboratory indexes ALT> 80U/L, renal function laboratory index Male: Cr> 200umol/L, female: Cr> 145.5 u mol/L); 5) Patients with a history of mental illness or dementia; 6) Significant drug or alcohol abuse; 7) Allergies and allergies to two or more drugs or foods; Or is known to be allergic to the ingredient; 8) Women who are pregnant, planning to be pregnant or breastfeeding; 9) Participated in other clinical trials in the past 3 months; 10) Patients deemed ineligible for this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short chain fatty acid;blood fat;Glycosylated hemoglobin;Vascular endothelial growth factor;Basic fibroblast growth factor;Angiopoietin;CD34+; | — |
Countries
China
Contacts
Public ContactXiangjian Zhang
The Second Hospital of Hebei Medical University
Outcome results
None listed